Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital

Efficacy of treatment intensification with adalimumab, etanercept and infliximab in rheumatoid arthritis: a systematic review of cohort studies with focus on dose

Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
To summarize the empirical evidence regarding the effect of treatment intensification on clinical outcomes in patients with rheumatoid arthritis treated with one of the TNF-α-inhibitors, adalimumab, etanercept or infliximab.
Original languageEnglish
JournalSeminars in Arthritis and Rheumatism
Issue number2
Pages (from-to)144-51
Number of pages8
Publication statusPublished - Oct 2013

ID: 42570271